Genetics of Congenital Heart Disease: Past and Present

Area of Science:

• Cardiovascular Science
• Genetics
• Developmental Biology

Background:

• Congenital heart disease (CHD) is the most frequent congenital anomaly, leading to significant infant morbidity and mortality.
• CHD encompasses various heart defects like septal, valve, and outflow tract anomalies.
• The precise genetic, epigenetic, and environmental factors underlying CHD are complex and multifactorial, remaining incompletely understood.

Purpose of the Study:

• To review the historical and recent genetic discoveries related to congenital heart disease.
• To highlight the accelerating role of advanced technologies in identifying genetic causes of heart anomalies.
• To discuss the emerging roles of microRNAs and epigenetic factors in cardiac development and CHD.

Main Methods:

• Literature review of past and recent studies on congenital heart disease genetics.
• Analysis of advancements in high-throughput technologies such as copy number variants, single-nucleotide polymorphism arrays, and next-generation sequencing.
• Inclusion of research on non-coding RNAs (microRNAs) and epigenetic modifications impacting cardiac morphogenesis.

Main Results:

• Advanced technologies are significantly improving the detection rates of genetic causes for heart anomalies.
• Emerging evidence points to a crucial role for small non-coding RNAs, specifically microRNAs, in the pathogenesis of CHD.
• Epigenetic factors are increasingly recognized for their contribution to normal cardiac development and potential involvement in CHD.

Conclusions:

• Genetic and epigenetic factors play a significant role in the etiology of congenital heart disease.
• Technological advancements are crucial for unraveling the genetic underpinnings of CHD.
• Further research into microRNAs and epigenetic mechanisms is essential for understanding and potentially treating CHD.